Seegene reports solid results in the first quarter of 2021 w

Seegene reports solid results in the first quarter of 2021 with KRW [...]


12 maggio 2021 06:46
Fonte: Adnkronos
#chimica-e-farmacia
SEOUL, South Korea, May 12, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for the first quarter of 2021, with reports showing robust earnings. The biotechnology firm posted KRW 351.8 billion in consolidated revenue, a 330% increase compared to the same period last year and a record for the first quarter. Operating profit at KRW 193.9 billion, also up 388% on-year, reflecting steady growth in its sales of diagnostic tests.
Seegene's Senior Managing Director of IR and PR Department Myungkun Kim said "the company was able to manage 55% of annual operating profit ratio, a clear reflection of its ability to effectively manage the firm despite the constant investment in R&D and expansion of manpower." He added that "once investments come to fruition, the operating profit ratio will likely surge even further."

Related Keywords

Germany , Italy , Seoul , Soult Ukpyolsi , South Korea , United Kingdom , Scotland , , Pr Department Myungkun Kim , Prnewswire Seegene Inc , Senior Managing Director , Myungkun Kim , Seegene , Reports , Solid , Results , The , First , Quarter , Of , 2021 , With , Krw , ஜெர்மனி , இத்தாலி , சியோல் , தெற்கு கொரியா , ஒன்றுபட்டது கிஂக்டம் , ஸ்காட்லாந்து , மூத்தவர் நிர்வகித்தல் இயக்குனர் , அறிக்கைகள் , திட , முடிவுகள் , தி , முதல் , காலாண்டு , ஆஃப் , உடன் , க்ர்வ் ,

© 2025 Vimarsana